Oncopeptides AB (ONCO) — Long-term Investment Intensity
Oncopeptides AB (ONCO) has a Long-term Investment Intensity of 0.3% as of December 2019. Long-term investments of Skr3.30 Million represent 0.3% of total assets of Skr993.49 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of Oncopeptides AB to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Oncopeptides AB Long-term Investment Intensity (2017–2019)
This chart shows how Oncopeptides AB's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2019. As of December 2019, the intensity stands at 0.3%, reflecting long-term investments of Skr3.30 Million against total assets of Skr993.49 Million SEK. Explore ONCO operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Oncopeptides AB (2017–2019)
The table below presents the year-by-year Long-term Investment Intensity for Oncopeptides AB from 2017 to 2019, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Oncopeptides AB (ONCO) market capitalisation.
| Year | LT Investment Intensity | LT Investments (SEK) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.3% | Skr3.30 Million | Skr993.49 Million | ▲ +0.3 pp |
| 2017 | 0.1% | Skr263.00K | Skr479.82 Million | — |